Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eloxx Pharmaceuticals, Inc. | HEAD OF R&D | Stock Options (Right to Buy) | 30K | Jan 25, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELOX | Eloxx Pharmaceuticals, Inc. | Jan 25, 2023 | 1 | $0 | 4 | Jan 27, 2023 | HEAD OF R&D |
ELOX | Eloxx Pharmaceuticals, Inc. | Dec 1, 2021 | 3 | -$46.3K | 4 | Dec 3, 2021 | HEAD OF R&D |
ELOX | Eloxx Pharmaceuticals, Inc. | May 18, 2021 | 1 | $0 | 4 | May 18, 2021 | HEAD OF R&D |